RenovoRx, Inc. Reports Q3 2026 Financial Results

What Happened

• RenovoRx, Inc. (RNXT) announced its financial results for the quarter ended June 30, 2026 in a press release dated August 12, 2026. The company filed an 8-K on August 13, 2026 (Item 2.02) to report these results and incorporated the press release by reference (Exhibit 99.1).

Key Details

• Filing: Form 8‑K filed August 13, 2026 reporting results of operations and financial condition (Item 2.02).
• Reporting period: Quarter ended June 30, 2026.
• Disclosure: Press release announcing the results is attached as Exhibit 99.1 to the 8‑K (and incorporated by reference).
• Interactive data: Cover page interactive XBRL file included as Exhibit 104 in the filing.

Why It Matters

• This 8‑K signals that RenovoRx has released its latest quarterly earnings and related financial information; investors should read the attached press release (Exhibit 99.1) for specifics on revenue, net loss/profit, cash position, and any operational highlights.
• The filing provides the official disclosure of quarterly results required for assessing near‑term performance; any changes to guidance, material financial metrics, or cash runway would be found in the press release and subsequent filings.